Are you a pharmaceutical or biotech manufacturer preparing to commercialize a drug and wondering how to support your Phase ...

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...

Why is collaboration between industry and academia necessary in the life sciences sector? What obstacles exist, and what is ...

The Swedish national life science strategy was launched in December 2019, and it has now been updated with a new government ...

- Automation of complex in vitro model generation and quantification at scale - Brightfield and fluorescent imaging ...

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.

Svenskutvecklade alzheimerläkemedlet lecanemab får ett positivt utlåtande från den europeiska läkemedelsmyndighetens kommitté för humanläkemedel, CHMP.

Cancercellers genetiska variation kan utnyttjas för få ut större effekt av redan godkända läkemedel, enligt en studie från ...

Okunniga, oseriösa och ibland kriminella aktörer är ett växande hot mot patientsäkerheten inom skönhetsingrepp i estetiskt ...